Mark Kamps - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 

55/122 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T, Fukushima H, Nanmoku T, Terui K, Ito T, Toki T, Ito E, Fujimura J, Goto H, Endo M, ... ... Kamps M, et al. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. Cancer Medicine. PMID 31305009 DOI: 10.1002/Cam4.2356  0.303
2012 Li D, Yang H, Nan H, Liu P, Pang S, Zhao Q, Karni R, Kamps MP, Xu Y, Zhou J, Wiedmer T, Sims PJ, Wang F. Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model. Blood. 120: 4712-9. PMID 23086752 DOI: 10.1182/Blood-2012-03-414979  0.313
2009 Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes & Development. 23: 2824-38. PMID 20008934 DOI: 10.1101/Gad.1861209  0.651
2009 Scheele JS, Kolanczyk M, Gantert M, Zemojtel T, Dorn A, Sykes DB, Sykes DP, Möbest DC, Kamps MP, Räpple D, Duchniewicz M. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1. Leukemia & Lymphoma. 50: 816-28. PMID 19399691 DOI: 10.1080/10428190902836107  0.601
2009 Jürgens AS, Kolanczyk M, Moebest DC, Zemojtel T, Lichtenauer U, Duchniewicz M, Gantert MP, Hecht J, Hattenhorst U, Burdach S, Dorn A, Kamps MP, Beuschlein F, Räpple D, Scheele JS. PBX1 is dispensable for neural commitment of RA-treated murine ES cells. In Vitro Cellular & Developmental Biology. Animal. 45: 252-63. PMID 19148706 DOI: 10.1007/s11626-008-9162-5  0.345
2007 Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nature Cell Biology. 9: 804-12. PMID 17589499 DOI: 10.1038/ncb1608  0.696
2007 Odegaard JI, Vats D, Zhang L, Ricardo-Gonzalez R, Smith KL, Sykes DB, Kamps MP, Chawla A. Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages. Journal of Leukocyte Biology. 81: 711-9. PMID 17158607 DOI: 10.1189/Jlb.0906590  0.58
2007 Wang GG, Kamps MP. Survival signaling in HoxA9/Meis1 AML Blood. 109: 3619-3620. DOI: 10.1182/blood-2007-02-072785  0.605
2006 Wang GG, Pasillas MP, Kamps MP. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Molecular and Cellular Biology. 26: 3902-16. PMID 16648484 DOI: 10.1128/MCB.26.10.3902-3916.2006  0.728
2006 Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nature Methods. 3: 287-93. PMID 16554834 DOI: 10.1038/Nmeth865  0.737
2006 Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, Mann M, Karin M. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 439: 204-7. PMID 16306937 DOI: 10.1038/Nature04369  0.654
2005 Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 106: 254-64. PMID 15755900 DOI: 10.1182/blood-2004-12-4664  0.717
2005 Wang GG, Pasillas MP, Kamps MP. Fusion to Vp16 Converts MEIS1 into an Oncoprotein That Immortalizes Progenitors and Causes AML in the Absence of Coexpressed Hox Genes: Hoxa7 and Hoxa9 Induced Further Stem Cell Gene Transcription in Vp16MEIS1 Progenitors. Blood. 106: 662-662. DOI: 10.1182/blood.v106.11.662.662  0.725
2004 Rave-Harel N, Givens ML, Nelson SB, Duong HA, Coss D, Clark ME, Hall SB, Kamps MP, Mellon PL. TALE homeodomain proteins regulate gonadotropin-releasing hormone gene expression independently and via interactions with Oct-1. The Journal of Biological Chemistry. 279: 30287-97. PMID 15138251 DOI: 10.1074/Jbc.M402960200  0.313
2004 Sykes DB, Kamps MP. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Molecular and Cellular Biology. 24: 1256-69. PMID 14729970 DOI: 10.1128/Mcb.24.3.1256-1269.2004  0.565
2003 Sykes DB, Scheele J, Pasillas M, Kamps MP. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein. Leukemia & Lymphoma. 44: 1187-99. PMID 12916872 DOI: 10.1080/1042819031000090273  0.615
2003 Sykes DB, Kamps MP. Estrogen-regulated conditional oncoproteins: tools to address open questions in normal myeloid cell function, normal myeloid differentiation, and the genetic basis of differentiation arrest in myeloid leukemia. Leukemia & Lymphoma. 44: 1131-9. PMID 12916864 DOI: 10.1080/1042819031000063444  0.604
2002 Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 21: 4247-56. PMID 12082612 DOI: 10.1038/Sj.Onc.1205516  0.711
2002 Klappacher GW, Lunyak VV, Sykes DB, Sawka-Verhelle D, Sage J, Brard G, Ngo SD, Gangadharan D, Jacks T, Kamps MP, Rose DW, Rosenfeld MG, Glass CK. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell. 109: 169-80. PMID 12007404 DOI: 10.1016/S0092-8674(02)00714-6  0.595
2001 Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 98: 13120-5. PMID 11687616 DOI: 10.1073/Pnas.231115398  0.694
2001 Sykes DB, Kamps MP. Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood. 98: 2308-18. PMID 11588024 DOI: 10.1182/Blood.V98.8.2308  0.619
2001 Knoepfler PS, Sykes DB, Pasillas M, Kamps MP. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene. 20: 5440-8. PMID 11571641 DOI: 10.1038/Sj.Onc.1204710  0.628
2000 Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Molecular and Cellular Biology. 20: 3274-85. PMID 10757811 DOI: 10.1128/Mcb.20.9.3274-3285.2000  0.712
1999 Calvo KR, Knoepfler P, McGrath S, Kamps MP. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 18: 8033-43. PMID 10637514 DOI: 10.1038/Sj.Onc.1203377  0.57
1999 Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene. 18: 4920-9. PMID 10490826 DOI: 10.1038/sj.onc.1202874  0.348
1997 Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proceedings of the National Academy of Sciences of the United States of America. 94: 14553-8. PMID 9405651 DOI: 10.1073/Pnas.94.26.14553  0.603
1997 Knoepfler PS, Kamps MP. The Pbx family of proteins is strongly upregulated by a post-transcriptional mechanism during retinoic acid-induced differentiation of P19 embryonal carcinoma cells. Mechanisms of Development. 63: 5-14. PMID 9178252 DOI: 10.1016/S0925-4773(97)00669-2  0.344
1997 Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Molecular and Cellular Biology. 17: 1503-12. PMID 9032278 DOI: 10.1128/Mcb.17.3.1503  0.37
1997 Lu Q, Kamps MP. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene. 14: 75-83. PMID 9010234 DOI: 10.1038/sj.onc.1200799  0.328
1996 Lu Q, Kamps MP. Selective repression of transcriptional activators by Pbx1 does not require the homeodomain. Proceedings of the National Academy of Sciences of the United States of America. 93: 470-4. PMID 8552663 DOI: 10.1073/pnas.93.1.470  0.328
1996 Kamps MP, Wright DD, Lu Q. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene. 12: 19-30. PMID 8552391  0.322
1995 Peers B, Sharma S, Johnson T, Kamps M, Montminy M. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Molecular and Cellular Biology. 15: 7091-7. PMID 8524276 DOI: 10.1128/Mcb.15.12.7091  0.388
1995 Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Molecular and Cellular Biology. 15: 3786-95. PMID 7791786 DOI: 10.1128/Mcb.15.7.3786  0.364
1995 Ogo A, Waterman MR, Kamps MP, Kagawa N. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein. The Journal of Biological Chemistry. 270: 25340-3. PMID 7592695 DOI: 10.1074/Jbc.270.43.25340  0.361
1994 Wright DD, Sefton BM, Kamps MP. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Molecular and Cellular Biology. 14: 2429-37. PMID 8139546  0.618
1994 Kamps MP, Wright DD. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene. 9: 3159-66. PMID 7936638  0.35
1994 Lu Q, Wright DD, Kamps MP. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Molecular and Cellular Biology. 14: 3938-48. PMID 7910944  0.388
1993 Kamps MP, Baltimore D. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Molecular and Cellular Biology. 13: 351-7. PMID 8093327 DOI: 10.1128/Mcb.13.1.351  0.512
1992 Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 79: 1781-8. PMID 1348433 DOI: 10.1182/Blood.V79.7.1781.Bloodjournal7971781  0.535
1991 Kamps MP, Look AT, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes & Development. 5: 358-68. PMID 1672117 DOI: 10.1101/Gad.5.3.358  0.479
1990 Kamps MP, Corcoran L, LeBowitz JH, Baltimore D. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Molecular and Cellular Biology. 10: 5464-72. PMID 2204815 DOI: 10.1128/Mcb.10.10.5464  0.47
1990 Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 60: 547-55. PMID 1967983 DOI: 10.1016/0092-8674(90)90658-2  0.498
1989 Kamps MP, Sefton BM. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. Analytical Biochemistry. 176: 22-7. PMID 2540676 DOI: 10.1016/0003-2697(89)90266-2  0.543
1988 Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 54: 553-60. PMID 3135941 DOI: 10.1016/0092-8674(88)90077-3  0.555
1988 Kamps MP, Sefton BM. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Oncogene Research. 3: 105-15. PMID 2465525  0.585
1988 Stern DF, Kamps MP, Cao H. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Molecular and Cellular Biology. 8: 3969-73. PMID 2464744 DOI: 10.1128/Mcb.8.9.3969  0.554
1988 Kamps MP, Sefton BM. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene. 2: 305-15. PMID 2452398  0.526
1988 Stern DF, Kamps MP. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. The Embo Journal. 7: 995-1001. DOI: 10.1002/J.1460-2075.1988.Tb02906.X  0.516
1986 Buss JE, Kamps MP, Gould K, Sefton BM. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. Journal of Virology. 58: 468-74. PMID 3009860 DOI: 10.1128/Jvi.58.2.468-474.1986  0.593
1986 Kamps MP, Buss JE, Sefton BM. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell. 45: 105-12. PMID 3006923 DOI: 10.1016/0092-8674(86)90542-8  0.585
1986 Kamps MP, Sefton BM. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Molecular and Cellular Biology. 6: 751-7. PMID 2430174 DOI: 10.1128/Mcb.6.3.751  0.614
1985 Kamps MP, Buss JE, Sefton BM. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proceedings of the National Academy of Sciences of the United States of America. 82: 4625-8. PMID 2991884 DOI: 10.1073/Pnas.82.14.4625  0.58
1985 Buss JE, Kamps MP, Sefton BM. Mutant p60(src)'s which lack myristic acid do not transform cells Federation Proceedings. 44: No. 4671.  0.551
1984 Buss JE, Kamps MP, Sefton BM. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Molecular and Cellular Biology. 4: 2697-704. PMID 6441887 DOI: 10.1128/Mcb.4.12.2697  0.553
1984 Kamps MP, Taylor SS, Sefton BM. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature. 310: 589-92. PMID 6431300 DOI: 10.1038/310589A0  0.583
Low-probability matches (unlikely to be authored by this person)
2007 Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, Kamps MP, Hammer GD, Scheele JS, Beuschlein F. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology. 148: 693-704. PMID 17082260 DOI: 10.1210/En.2006-0681  0.299
1999 Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Research. 27: 3752-61. PMID 10471746 DOI: 10.1093/Nar/27.18.3752  0.299
1997 White FC, Benehacene A, Scheele JS, Kamps M. VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways. Growth Factors (Chur, Switzerland). 14: 199-212. PMID 9255609 DOI: 10.3109/08977199709021520  0.29
2012 Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer RJ. The plasminogen receptor, Plg-R(KT), and macrophage function. Journal of Biomedicine & Biotechnology. 2012: 250464. PMID 23125524 DOI: 10.1155/2012/250464  0.284
1997 Kamps MP. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. Current Topics in Microbiology and Immunology. 220: 25-43. PMID 9103673  0.277
1997 Knoepfler PS, Kamps MP. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements. Oncogene. 14: 2521-31. PMID 9191052 DOI: 10.1038/Sj.Onc.1201097  0.268
1999 Fu X, Roberts WG, Nobile V, Shapiro R, Kamps MP. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors (Chur, Switzerland). 17: 125-37. PMID 10595312  0.267
1995 Knoepfler PS, Kamps MP. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Molecular and Cellular Biology. 15: 5811-9. PMID 7565734 DOI: 10.1128/Mcb.15.10.5811  0.25
1996 Lu Q, Kamps MP. Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex. Molecular and Cellular Biology. 16: 1632-40. PMID 8657138  0.242
2014 Dunlop EA, Seifan S, Claessens T, Behrends C, Kamps MA, Rozycka E, Kemp AJ, Nookala RK, Blenis J, Coull BJ, Murray JT, van Steensel MA, Wilkinson S, Tee AR. FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. Autophagy. 10: 1749-60. PMID 25126726 DOI: 10.4161/Auto.29640  0.232
2000 Jaw TJ, You LR, Knoepfler PS, Yao LC, Pai CY, Tang CY, Chang LP, Berthelsen J, Blasi F, Kamps MP, Sun YH. Direct interaction of two homeoproteins, homothorax and extradenticle, is essential for EXD nuclear localization and function. Mechanisms of Development. 91: 279-91. PMID 10704852 DOI: 10.1016/S0925-4773(99)00316-0  0.229
2010 Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer RJ, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 115: 1319-30. PMID 19897580 DOI: 10.1182/Blood-2008-11-188938  0.229
1989 Cartwright CA, Kamps MP, Meisler AI, Pipas JM, Eckhart W. pp60c-src activation in human colon carcinoma. The Journal of Clinical Investigation. 83: 2025-33. PMID 2498394 DOI: 10.1172/Jci114113  0.221
1996 Knoepfler PS, Lu Q, Kamps MP. Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3' to a TAAT motif. Nucleic Acids Research. 24: 2288-94. PMID 8710498 DOI: 10.1093/Nar/24.12.2288  0.214
1991 Kamps MP. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. Methods in Enzymology. 201: 101-10. PMID 1719339  0.212
1988 Stern DF, Kamps MP. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. The Embo Journal. 7: 995-1001. PMID 3261240  0.211
1996 White FC, Kamps M. Transcriptional Activation of the VEGF Gene by Okadaic Acid Qualitative Health Research. 6: 133-144.  0.2
2001 Novikov DK, Kamps ME. Characterization of the promoter region of the human peroxisomal multifunctional enzyme type 2 gene. Biochemical and Biophysical Research Communications. 284: 226-31. PMID 11374894 DOI: 10.1006/bbrc.2001.4949  0.2
2011 Pasillas MP, Shah M, Kamps MP. NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human sotos syndrome. Human Mutation. 32: 292-8. PMID 21972110 DOI: 10.1002/humu.21424  0.184
2014 Yan M, Gingras MC, Dunlop EA, Nouët Y, Dupuy F, Jalali Z, Possik E, Coull BJ, Kharitidi D, Dydensborg AB, Faubert B, Kamps M, Sabourin S, Preston RS, Davies DM, et al. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. The Journal of Clinical Investigation. 124: 2640-50. PMID 24762438 DOI: 10.1172/Jci71749  0.178
2013 Luijten MN, Basten SG, Claessens T, Vernooij M, Scott CL, Janssen R, Easton JA, Kamps MA, Vreeburg M, Broers JL, van Geel M, Menko FH, Harbottle RP, Nookala RK, Tee AR, et al. Birt-Hogg-Dube syndrome is a novel ciliopathy. Human Molecular Genetics. 22: 4383-97. PMID 23784378 DOI: 10.1093/hmg/ddt288  0.155
1988 Glenney JR, Zokas L, Kamps MP. Monoclonal antibodies to phosphotyrosine. Journal of Immunological Methods. 109: 277-85. PMID 2452204 DOI: 10.1016/0022-1759(88)90253-0  0.151
1981 Engels W, Kamps MA. Secretion of staphylocoagulase be Staphylococcus aureus: the role of a cell-bound intermediate. Antonie Van Leeuwenhoek. 47: 509-24. PMID 7337434  0.144
2009 Verstraeten VL, Caputo S, van Steensel MA, Duband-Goulet I, Zinn-Justin S, Kamps M, Kuijpers HJ, Ostlund C, Worman HJ, Briedé JJ, Le Dour C, Marcelis CL, van Geel M, Steijlen PM, van den Wijngaard A, et al. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. Journal of Cellular and Molecular Medicine. 13: 959-71. PMID 19220582 DOI: 10.1111/J.1582-4934.2009.00690.X  0.143
2017 Zhu Y, Gong K, Denholtz M, Chandra V, Kamps MP, Alber F, Murre C. Comprehensive characterization of neutrophil genome topology. Genes & Development. PMID 28167501 DOI: 10.1101/Gad.293910.116  0.14
2011 de Zwart-Storm EA, Rosa RF, Martin PE, Foelster-Holst R, Frank J, Bau AE, Zen PR, Graziadio C, Paskulin GA, Kamps MA, van Geel M, van Steensel MA. Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes. Experimental Dermatology. 20: 408-12. PMID 21410767 DOI: 10.1111/j.1600-0625.2010.01222.x  0.138
2009 Houben F, Willems CH, Declercq IL, Hochstenbach K, Kamps MA, Snoeckx LH, Ramaekers FC, Broers JL. Disturbed nuclear orientation and cellular migration in A-type lamin deficient cells. Biochimica Et Biophysica Acta. 1793: 312-24. PMID 19013199 DOI: 10.1016/j.bbamcr.2008.10.003  0.132
1995 White FC, Carroll SM, Kamps MP. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors (Chur, Switzerland). 12: 289-301. PMID 8930020 DOI: 10.3109/08977199509028967  0.128
1991 Kamps MP. Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. Methods in Enzymology. 201: 21-7. PMID 1719341  0.125
1997 Herold C, White F, McGrath S, Kamps MP. Constitutive stabilization of VEGF mRNA in human HT1080 fibrosarcoma cells is not mediated by mutations in 3 ′ UTR elements proposed to regulate mRNA stability Cardiovascular Pathobiology. 2: 88-96.  0.098
2012 Easton JA, Donnelly S, Kamps MA, Steijlen PM, Martin PE, Tadini G, Janssens R, Happle R, van Geel M, van Steensel MA. Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations. The Journal of Investigative Dermatology. 132: 2184-91. PMID 22592158 DOI: 10.1038/jid.2012.143  0.098
2005 Swelsen WT, Voorter CE, Tilanus MG, Kamps MA, van den Berg-Loonen EM. No HLA-A gene detectable on one of the haplotypes in a Caucasian family. Human Immunology. 66: 155-63. PMID 15695001 DOI: 10.1016/j.humimm.2004.10.009  0.088
2011 De Vos WH, Houben F, Kamps M, Malhas A, Verheyen F, Cox J, Manders EM, Verstraeten VL, van Steensel MA, Marcelis CL, van den Wijngaard A, Vaux DJ, Ramaekers FC, Broers JL. Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. Human Molecular Genetics. 20: 4175-86. PMID 21831885 DOI: 10.1093/hmg/ddr344  0.087
2006 Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. The Journal of Pathology. 210: 412-9. PMID 17054308 DOI: 10.1002/path.2070  0.077
1985 Engels W, Endert J, Kamps MA, van Boven CP. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa. Infection and Immunity. 49: 182-9. PMID 3924827  0.066
2013 Tamiello C, Kamps MA, van den Wijngaard A, Verstraeten VL, Baaijens FP, Broers JL, Bouten CC. Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations. Nucleus (Austin, Tex.). 4: 61-73. PMID 23324461 DOI: 10.4161/nucl.23388  0.062
2011 Verstraeten VL, Renes J, Ramaekers FC, Kamps M, Kuijpers HJ, Verheyen F, Wabitsch M, Steijlen PM, van Steensel MA, Broers JL. Reorganization of the nuclear lamina and cytoskeleton in adipogenesis. Histochemistry and Cell Biology. 135: 251-61. PMID 21350821 DOI: 10.1007/s00418-011-0792-4  0.06
1982 Engels W, Kamps MA. The nature of the competitive ability of spontaneous staphylocoagulase-negative mutants of Staphylococcus aureus with respect to growth of the parent strains in continuous culture. Antonie Van Leeuwenhoek. 48: 67-83. PMID 7092203  0.055
1981 Engels W, Kamps M. The competitive ability of spontaneous staphylocoagulase-negative mutants of Staphylococcus aureus 104 and NCTC 8178 towards the parent strains in continuous culture. Antonie Van Leeuwenhoek. 47: 90-1. PMID 7247395  0.051
1996 Chapman SA, Lake KD, Solbrack DF, Milfred SK, Marshall PS, Kamps MA. Considerations for using ketoconazole in solid organ transplant recipients receiving cyclosporine immunosuppression. Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (Natco). 6: 148-54. PMID 9188374 DOI: 10.7182/PRTR.1.6.3.660840145V3G3631  0.041
1980 Engels W, Kamps MA, van Boven CP. Continuous culture studies on the production of staphylocoagulase by Staphylococcus aureus. Antonie Van Leeuwenhoek. 46: 533-50. PMID 6786215  0.041
1994 Roth D, Lücke M, Kamps M, Schmitz R. Phase dynamics of patterns: The effect of boundary-induced amplitude variations. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics. 50: 2756-2775. PMID 9962314  0.038
2006 Verstraeten VL, Broers JL, van Steensel MA, Zinn-Justin S, Ramaekers FC, Steijlen PM, Kamps M, Kuijpers HJ, Merckx D, Smeets HJ, Hennekam RC, Marcelis CL, van den Wijngaard A. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Human Molecular Genetics. 15: 2509-22. PMID 16825282 DOI: 10.1093/hmg/ddl172  0.038
2014 Kamps MJ, Horn J, Oddo M, Fugate JE, Storm C, Cronberg T, Wu O, Binnekade JM, Hoedemaekers CW. Response to De Jonghe et al.: Prognostication of neurological outcome after cardiac arrest: standardization of neurological examination conditions is needed. Intensive Care Medicine. 40: 295. PMID 24306085 DOI: 10.1007/s00134-013-3178-3  0.034
1981 Engels W, Kamps MA, van Boven CP. Rapid and direct staphylocoagulase assay that uses a chromogenic substrate for identification of Staphylococcus aureus. Journal of Clinical Microbiology. 14: 496-500. PMID 7309847  0.033
1999 Kandaswamy R, Kamps M, Matas AJ. Administration of OKT3 as a two-hour infusion does not attenuate first-dose side effects. Transplantation. 68: 709-10. PMID 10507495 DOI: 10.1097/00007890-199909150-00021  0.026
2013 Kamps MJ, Horn J, Oddo M, Fugate JE, Storm C, Cronberg T, Wijman CA, Wu O, Binnekade JM, Hoedemaekers CW. Prognostication of neurologic outcome in cardiac arrest patients after mild therapeutic hypothermia: a meta-analysis of the current literature. Intensive Care Medicine. 39: 1671-82. PMID 23801384 DOI: 10.1007/s00134-013-3004-y  0.026
1978 Engels W, Kamps M, van Boven CP. Influence of cultivation conditions on the production of staphylocoagulase by Staphylococcus aureus 104. Journal of General Microbiology. 109: 237-43. PMID 34009  0.025
1989 Barten W, Lücke M, Hort W, Kamps M. Fully developed traveling-wave convection in binary fluid mixtures. Physical Review Letters. 63: 376-379. PMID 10041057  0.025
2014 Kamps MJA, Vermeulen Windsant-van den tweel AMA, de Jager CPC. Intoxication with ethylene glycol treated with fomepizole: A case report Netherlands Journal of Critical Care. 18: 24-26.  0.025
2002 Hopman AH, Kamps MA, Speel EJ, Schapers RF, Sauter G, Ramaekers FC. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. The American Journal of Pathology. 161: 1119-25. PMID 12368185 DOI: 10.1016/S0002-9440(10)64388-X  0.023
1988 Engels W, Kamps MA, Lemmens PJ, van der Vusse GJ, Reneman RS. Determination of prostaglandins and thromboxane in whole blood by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography. 427: 209-18. PMID 3410908  0.021
1987 Engels W, van Bilsen M, van der Vusse GJ, Willemsen PH, Coumans WA, Kamps MA, Endert J, Reneman RS. Influence of intracellular Ca2+-overload in eicosanoid synthesis of the myocardium. Basic Research in Cardiology. 82: 245-51. PMID 3117031  0.019
1996 Roth D, Büchel P, Lücke M, Müller HW, Kamps M, Schmitz R. Influence of boundaries on pattern selection in through-flow Physica D: Nonlinear Phenomena. 97: 253-263.  0.019
1993 Speel EJ, Kamps M, Bonnet J, Ramaekers FC, Hopman AH. Multicolour preparations for in situ hybridization using precipitating enzyme cytochemistry in combination with reflection contrast microscopy. Histochemistry. 100: 357-66. PMID 8307777  0.019
1991 Eaton KD, Ohlsen DR, Yamamoto SY, Surko CM, Barten W, Lücke M, Kamps M, Kolodner P. Concentration field in traveling-wave and stationary convection in fluid mixtures. Physical Review. A. 43: 7105-7108. PMID 9905075 DOI: 10.1103/Physreva.43.7105  0.018
1995 Barten W, Lücke M, Kamps M, Schmitz R. Convection in binary fluid mixtures. I. Extended traveling-wave and stationary states. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics. 51: 5636-5661. PMID 9963298  0.017
2011 Kamps M, Bisschops LA, van der Hoeven JG, Hoedemaekers CW. Hypothermia does not increase the risk of infection: a case control study. Critical Care (London, England). 15: R48. PMID 21291523 DOI: 10.1186/cc10012  0.012
1991 Barten W, Lücke M, Kamps M. Localized traveling-wave convection in binary-fluid mixtures. Physical Review Letters. 66: 2621-2624. PMID 10043569  0.012
2014 Kunneman M, Pieterse AH, Stiggelbout AM, Nout RA, Kamps M, Lutgens LC, Paulissen J, Mattheussens OJ, Kruitwagen RF, Creutzberg CL. Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians. British Journal of Cancer. 111: 674-9. PMID 24921911 DOI: 10.1038/bjc.2014.322  0.012
2005 Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. International Journal of Cancer. Journal International Du Cancer. 115: 419-28. PMID 15688369 DOI: 10.1002/ijc.20862  0.012
1995 Barten W, Lücke M, Kamps M, Schmitz R. Convection in binary fluid mixtures. II. Localized traveling waves. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics. 51: 5662-5680. PMID 9963299  0.011
2013 Houben F, De Vos WH, Krapels IP, Coorens M, Kierkels GJ, Kamps MA, Verstraeten VL, Marcelis CL, van den Wijngaard A, Ramaekers FC, Broers JL. Cytoplasmic localization of PML particles in laminopathies. Histochemistry and Cell Biology. 139: 119-34. PMID 22918509 DOI: 10.1007/s00418-012-1005-5  0.01
2000 Kamps M. Immunosuppressive medications: How much do they really cost and how can anyone afford them? Transplantation Reviews. 14: 168-175.  0.01
1992 Müller HW, Lücke M, Kamps M. Transversal convection patterns in horizontal shear flow. Physical Review. A. 45: 3714-3726. PMID 9907419  0.01
1992 Shepherd MF, Lake KD, Kamps MA. Postmortem changes and pharmacokinetics: review of the literature and case report. The Annals of Pharmacotherapy. 26: 510-4. PMID 1533552  0.01
1969 Kamps M. [Plastic surgery. Why?]. Nursing. 41: 1-2. PMID 5197612  0.01
Hide low-probability matches.